Predictions
Lyxor Ucits Etf Euro Cash (fcp)
Start price
Target price
Perf. (%)
€105.09
23.08.23
23.08.23
-
23.08.24
23.08.24
0.86%
14.11.23
14.11.23
Royal Bank of Canada
Start price
Target price
Perf. (%)
€81.87
22.08.23
22.08.23
€114.35
22.08.24
22.08.24
27.61%
18:48
18:48
Readcrest Capital AG
Start price
Target price
Perf. (%)
€1.10
21.08.23
21.08.23
€0.000
21.08.24
21.08.24
-10.91%
02.09.23
02.09.23
Capable Management
Risky Investment
Business model of the past or high risk
Adicet Bio Inc.
Start price
Target price
Perf. (%)
€1.64
21.08.23
21.08.23
-
21.08.24
21.08.24
7.27%
02.09.23
02.09.23
Could be very worthwhile Investment >20% year
Leap Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.77
21.08.23
21.08.23
-
21.08.24
21.08.24
5.08%
02.09.23
02.09.23
Could be worthwhile Investment >10% per year
Cellectar BioSciences Inc.
Start price
Target price
Perf. (%)
€1.45
20.08.23
20.08.23
-
20.08.24
20.08.24
24.83%
14.08.24
14.08.24
China Recycling Energy Corp.
Start price
Target price
Perf. (%)
€0.96
20.08.23
20.08.23
-
20.08.24
20.08.24
-21.35%
16.08.24
16.08.24
Cyclacel Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€0.37
20.08.23
20.08.23
-
20.08.24
20.08.24
-53.77%
15.12.23
15.12.23
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€1.00
20.08.23
20.08.23
-
20.08.24
20.08.24
-74.52%
19.07.24
19.07.24
Adicet Bio Inc.
Start price
Target price
Perf. (%)
€1.64
20.08.23
20.08.23
€0.000
20.08.24
20.08.24
7.27%
03.09.23
03.09.23
High risks for its business
Business model of the past or high risk
Probably not worthwhile Investment
Revenue decline/stagnation expected
ifa systems AG
Start price
Target price
Perf. (%)
€3.16
20.08.23
20.08.23
€0.000
20.08.24
20.08.24
-5.70%
03.09.23
03.09.23
Revenue decline/stagnation expected
Decining EBIT margin than peer group
EBIT decline/stagnation expected
High valuation
Cosmos Health Inc.
Start price
Target price
Perf. (%)
€1.27
19.08.23
19.08.23
-
19.08.24
19.08.24
-23.79%
19.01.24
19.01.24
Probably not worthwhile Investment
Chalice Gold Mines Ltd
Start price
Target price
Perf. (%)
€2.88
18.08.23
18.08.23
-
18.08.26
18.08.26
-77.38%
16:19
16:19
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected